Professional societies have stepped up efforts to minimize administered activity, based on updated dosage cards and guidelines. Medical physicists recognize that while these protocols are helpful, there is room for improvement.

Iodine-131 is lauded for its specificity in targeting thyroid lesions. Yet, some experts are debating whether the treatment should be used across the board or stratified.

While whole-body oncology imaging advances are still emerging, the best modality remains to be seen.

In 2011, the FDA cleared I-123 ioflupane for dopamine transporter imaging, and an SNM expert provides coding advice for Parkinsonian syndromes.

Advancements in molecular neuroimaging are providing new ways to assess neuroinflammation in the brain.

With the aging population, the proliferation of neurodegenerative diseases, particularly Alzheimers, is becoming a truly global burden.

Technological improvements in image acquisition and software processing in nuclear cardiology should allow physicians to shave patient imaging times dramatically or cut radiation doses fourfold, according to a new preferred practice statement from the American Society of Nuclear Cardiology (ASNC).

Revelations about the actual cause of myocardial infarction have led researchers to seek out new ways to diagnose, evaluate, treat and prevent coronary artery disease, specifically through imaging vulnerable plaque.